These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 1000341

  • 21. Urinary excretion of hydroxyproline and hydroxylysyl glycosides in adjuvant-induced arthritis.
    Orloff S, Rao VH, Verbruggen L.
    Ital J Biochem; 1979; 28(3):173-82. PubMed ID: 553901
    [Abstract] [Full Text] [Related]

  • 22. Paget's disease of bone.
    Krane SM.
    Clin Orthop Relat Res; 1977; (127):24-36. PubMed ID: 410574
    [No Abstract] [Full Text] [Related]

  • 23. Pre-column derivatization and its optimum conditions for quantitative determination of urinary hydroxylysine glycosides by high-performance liquid chromatography.
    Yoshihara K, Mochidome N, Shida Y, Hayakawa Y, Nagata M.
    Biol Pharm Bull; 1993 Jun; 16(6):604-7. PubMed ID: 8364515
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Urinary output of hydroxylysine glycosides and pyridinium cross-links in detecting rat bone collagen turnover rate.
    Grazioli V, Alfano M, Stenico A, Casari E.
    FEBS Lett; 1996 Jun 17; 388(2-3):134-8. PubMed ID: 8690072
    [Abstract] [Full Text] [Related]

  • 26. Collagen markers deoxypyridinoline and hydroxylysine glycosides: pediatric reference data and use for growth prediction in growth hormone-deficient children.
    Rauch F, Georg M, Stabrey A, Neu C, Blum WF, Remer T, Manz F, Schoenau E.
    Clin Chem; 2002 Feb 17; 48(2):315-22. PubMed ID: 11805013
    [Abstract] [Full Text] [Related]

  • 27. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
    Shai F, Baker RK, Wallach S.
    J Clin Invest; 1971 Sep 17; 50(9):1927-40. PubMed ID: 4935444
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
    Garnero P, Gineyts E, Riou JP, Delmas PD.
    J Clin Endocrinol Metab; 1994 Sep 17; 79(3):780-5. PubMed ID: 8077361
    [Abstract] [Full Text] [Related]

  • 30. [Increased excretion of glucosyl-galactosyl-hydroxylysine in urine during glomerulonephritis with nephrotoxic antibodies in the rat].
    Sternberg MM, Tremblay C, Raghavan C, Carter M, Skwarlo K, Lagrue G.
    C R Acad Hebd Seances Acad Sci D; 1974 Aug 19; 279(8):687-90. PubMed ID: 4215593
    [No Abstract] [Full Text] [Related]

  • 31. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases.
    Robins SP, Black D, Paterson CR, Reid DM, Duncan A, Seibel MJ.
    Eur J Clin Invest; 1991 Jun 19; 21(3):310-5. PubMed ID: 1909635
    [Abstract] [Full Text] [Related]

  • 32. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
    Kaddam IM, Iqbal SJ, Holland S, Wong M, Manning D.
    Ann Clin Biochem; 1994 Jul 19; 31 ( Pt 4)():327-30. PubMed ID: 7979096
    [Abstract] [Full Text] [Related]

  • 33. Effects of prolonged thyrocalcitonin administration on Paget's disease of bone.
    Haddad JG, Birge SJ, Avioli LV.
    N Engl J Med; 1970 Sep 10; 283(11):549-55. PubMed ID: 5450609
    [No Abstract] [Full Text] [Related]

  • 34. Urinary excretions of hydroxylysylglycosides in rats with experimentally induced collagen-like syndrome.
    Jendryczko A, Drozdz M, Magner K.
    Biomed Biochim Acta; 1985 Sep 10; 44(7-8):1133-7. PubMed ID: 2417593
    [Abstract] [Full Text] [Related]

  • 35. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
    Alvarez L, Peris P, Pons F, Guañabens N, Herranz R, Monegal A, Bedini JL, Deulofeu R, Martínez de Osaba MJ, Muñoz-Gómez J, Ballesta AM.
    Arthritis Rheum; 1997 Mar 10; 40(3):461-8. PubMed ID: 9082934
    [Abstract] [Full Text] [Related]

  • 36. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
    Garnero P, Fledelius C, Gineyts E, Serre CM, Vignot E, Delmas PD.
    J Bone Miner Res; 1997 Sep 10; 12(9):1407-15. PubMed ID: 9286756
    [Abstract] [Full Text] [Related]

  • 37. [Hydroxyprolinuria in skeletal diseases: its correlation with other parameters of bone metabolism].
    Courvoisier B, Zender R.
    Schweiz Med Wochenschr; 1972 Feb 05; 102(5):160-6. PubMed ID: 5010800
    [No Abstract] [Full Text] [Related]

  • 38. Paget's disease of bone (osteitis deformans) treated with human synthetic calcitonin.
    Epstein S, Owen G.
    S Afr Med J; 1977 Jan 29; 51(5):133-7. PubMed ID: 850845
    [Abstract] [Full Text] [Related]

  • 39. Early effects of calcitonin on urinary excretion of calcium and 47calcium in Paget's disease.
    Gennari C, Vattimo A.
    J Nucl Biol Med; 1975 Jan 29; 19(2):73-9. PubMed ID: 1165495
    [No Abstract] [Full Text] [Related]

  • 40. [Determination of urinary hydroxylysine glycosides].
    Daĭkhin EI, Mazhuga NA, Ananenko AA.
    Lab Delo; 1979 Jan 29; (7):293-5. PubMed ID: 89224
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.